O'Brien Wealth Partners LLC Pfizer Inc Transaction History

O'Brien Wealth Partners LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $1,861 - $2,175	-58 Reduced 3.05%	1,842 $61,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $2,094 - $2,423	-58 Reduced 2.96%	1,900 $69,000
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $19,104 - $24,870	-485 Reduced 19.85%	1,958 $79,000
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $18,871 - $24,634	-452 Reduced 15.61%	2,443 $125,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1,269 - $1,549	29 Added 1.01%	2,895 $127,000
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $4,978 - $5,903	-107 Reduced 3.6%	2,866 $150,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $19,581 - $24,263	428 Added 16.82%	2,973 $145,000
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $23,593 - $34,973	571 Added 28.93%	2,545 $132,000
Q3 2021 Oct 07, 2021	BUY	$39.25 - $50.42 $77,479 - $99,529	1,974 New	1,974 $84,000
Q1 2020 Apr 03, 2020	SELL	$27.03 - $38.62 $140,961 - $201,403	-5,215 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$32.92 - $37.36 $171,677 - $194,832	5,215 New	5,215 $203,000
Q3 2019 Oct 04, 2019	SELL	$32.49 - $42.13 $174,438 - $226,195	-5,369 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$36.98 - $41.52 $24,000 - $26,946	-649 Reduced 10.78%	5,369 $236,000
Q1 2019 Apr 05, 2019	SELL	$37.5 - $41.2 $120,787 - $132,705	-3,221 Reduced 34.86%	6,018 $256,000
Q3 2018 Oct 09, 2018	BUY	$34.47 - $41.81 $318,468 - $386,282	9,239 New	9,239 $407,000
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $64,475 - $68,737	-1,955 Closed	0 $0
Q1 2018 Apr 11, 2018	BUY	$31.91 - $37.02 $62,384 - $72,374	1,955 New	1,955 $69,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of O'Brien Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on O'Brien Wealth Partners LLC with notifications on news.